Silo Wellness Inc. (CSE: SILO) (FRA:3K70), a leading wellness company in the psychedelics and functional mushroom market, is pleased to announce the appointment of its newest board member, Wayne Isaacs. A seasoned Jamaican-Canadian businessman, Isaacs is a recognized leader in the natural, plant-based medicine industry. This appointment follows the recent passing of board member Maurice ‘Moe’ Colson.
With nearly two decades of experience serving in key leadership roles from President to Chief Executive Officer for several Toronto-based mineral exploration companies, including Forsys Metals Corporation, Augustine Ventures, Inc., and Delta Uranium, Inc., Isaacs is a valuable addition to the board. He has been a pioneer in the legalized Jamaican cannabis industry, and currently serves as CEO of Green Stripe Naturals. This company, formed to leverage global opportunities in medicinal cannabis, employs vertically integrated business efforts on the island nation. Isaacs also co-owns a medical clinic in Ontario, Canada and holds business interests in natural medicine-based solutions companies in Spain.
Douglas K. Gordon, Chief Executive Officer of Silo Wellness, warmly welcomes Wayne Isaacs to the board, commending Isaacs’ foresight and business acumen as a key player in the legal cannabis movement in Jamaica. Isaacs’ vast leadership experience in the public sector and his expertise in plant-based wellness will add great value to Silo Wellness, particularly as the company looks to expand globally.
Born in Jamaica, Isaacs was educated at the prestigious Western University in Ontario. He has spent the majority of his career on Bay Street, specializing in the resource sector both as a corporate executive and as an investment banker. In addition to serving on various corporate boards and holding leadership roles in public and private companies, Isaacs often participates in international industry and thought leadership conferences as a panelist, presenter, and speaker.
In his own statement, Isaacs expressed his attraction to serving as a board member for Silo Wellness, highlighting the opportunity to provide strategic consultation to the company’s unique product offering. He committed to advancing the mission of Silo Wellness, aiming to bring the positive benefits of psilocybin to a broader consumer audience, emerging markets, and the medical community.
To commemorate Isaacs’ appointment, Silo Wellness has granted him 200,000 stock options, pursuant to their stock option plan. These options vest immediately and may be exercised at a price of $0.25 per common share for a period of five years from the date of issue.
About Silo Wellness: The mission of Silo Wellness is to improve health and wellness by developing and introducing psychedelic medicine to reduce trauma and increase performance. This is achieved by destigmatizing the active compounds in psychedelics and innovating ease of administration and ingestion. Silo Wellness aims to introduce new, safe, and affordable alternatives to current medicines by facilitating entry into new and emerging markets where psychedelics are legal, conducting ketamine and psilocybin wellness retreats, and manufacturing and distributing functional mushrooms.
For further information, please contact www.silowellness.com. Media Relations: [email protected]. Silo Wellness Investor Relations: (604) 343-2724, [email protected].
CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION: This news release contains forward-looking information and statements within the meaning of the applicable Canadian securities legislation. Other than statements of historical fact, all statements are forward-looking and are based on expectations, estimates, and projections as at the date of this news release. In this news release, forward-looking statements relate, among other things, to the appointment of Mr. Isaacs, the grant of incentive stock options, and the business plans of Silo Wellness. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
